The FDA recently released results of a review that found an increased risk of aortic ruptures or tears with the use of fluoroquinolones. As part of the safety warning, the FDA has recommendations for providers, including avoidance of fluoroquinolones in patients with a history of aortic aneurysm or those at risk for an aneurysm; to
